Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-06 | New | $55,999,997 | $55,999,997 | Equity Only | 06b | SEC link |
| 2023-09-25 | New | $20,000,000 | $20,000,000 | Equity Only | 06b | SEC link |
| 2022-12-19 | New | $8,229,699 | $8,229,699 | Debt Only | 06b | SEC link |
| 2020-11-03 | New | $36,981,418 | $36,981,418 | Equity Only | 06b | SEC link |
| 2020-06-10 | New | $2,200,000 | $2,200,000 | Debt Only | 06b | SEC link |
| 2019-10-22 | New | $2,385,759 | $2,385,759 | Equity Only | 06b | SEC link |
| 2017-08-16 | New | $22,634,257 | $22,634,257 | Equity Only | 06c | SEC link |
| 2017-08-16 | New | $0 | $0 | Equity Only | 06c | SEC link |
| 2016-05-12 | New | Yet to Sell | $0 | Debt Only | 06c | SEC link |
| 2013-02-19 | New | $1,750,000 | $1,750,000 | Debt Only | 06 | SEC link |
| 2013-02-11 | Amended | $2,508,310 | $0 | Equity Only | 06 | SEC link |
| 2012-06-07 | New | $2,508,310 | $2,508,310 | Equity Only | 06 | SEC link |
| 2009-10-19 | New | $1,285,029 | Unknown | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Fouad Azzam | Director |
| Randy Ban | Director |
| Robert J. Centa | Executive |
| Scott F. Drees | Director |
| Joyce Erony | Director |
| William Harrington | Director |
| Stephen R. Haynes | Director |
| Joseph J. Jankowski | Director |
| Alan Kaganov | Director |
| Marc Andre Marcotte | Director |
| Anthony Natale | Director |
| Claiborne R. Rankin | Director |
| Jon J. Snyder | Director, Executive |
| Zach Stassen | Executive |
| Casey Tansey | Director |
| Mark W. Teague | Executive |
| David Veino | Director, Executive |
| Thomas C. Wilder | Director, Executive |